Enjoy complimentary customisation on priority with our Enterprise License!
The antacids market size is estimated to grow by USD 692.3 million at a CAGR of 3.27% between 2023 and 2028. The aging population is a significant global trend, with the number of people over 60 expected to double by 2050. Poor lifestyle choices, such as unhealthy diet, sedentary living, and smoking, contribute to the rising prevalence of chronic diseases, particularly in older adults. Another concern is the increasing use of Non-steroidal anti-inflammatory drugs (NSAIDs) for pain management, which can lead to adverse effects on the gastrointestinal tract and kidneys, especially in the elderly population. These factors underscore the need for effective and safe interventions to prevent and manage chronic diseases in older adults. Our company offers a range of evidence-based solutions, including nutraceuticals, lifestyle modifications, and pharmaceutical interventions, to help mitigate the health risks associated with aging and improve the quality of life for seniors.
For More Highlights About this Report, Request Free Sample
The market encompasses a range of over-the-counter (OTC) digestive products designed to neutralize stomach acid and provide relief from heartburn and indigestion. The market includes various types of antacids, such as sodium antacids, calcium antacids, magnesium antacids, and aluminum antacids, available in the form of tablets and liquids for oral use. These antacids find extensive application in managing gastrointestinal disorders, particularly in the geriatric population, who are more susceptible to acidity problems due to age-related factors. Heartburn, indigestion, and acidity are common conditions that affect millions worldwide, often caused by stress, smoking, alcohol consumption, obesity, and certain medications. Antacids offer quick relief from these symptoms. However, long-term use of antacids may lead to rebound hyperacidity, milk-alkali syndrome, and other health concerns.
Moreover, antacids are also used to manage conditions like peptic ulcers, oesophageal cancer, and Barrett's esophagus. Antacids containing aluminum hydroxide are often prescribed for these conditions. Proton pump inhibitors are another class of medications used for managing acidity-related conditions, but they are prescription-based and not part of the market. In summary, the antacids market caters to a significant consumer base, with a wide range of products addressing various acidity-related conditions and contributing to the overall growth of the market. Our researchers analyzed the data with 2023 as the base year, along with the key drivers, trends, and challenges. A holistic analysis of drivers will help companies refine their marketing strategies to gain a competitive advantage.
The rising geriatric population is notably driving market growth. The global market is witnessing significant growth due to the increasing prevalence of gastrointestinal disorders, particularly in the geriatric population. Heartburn symptoms, such as acid reflux and regurgitation, are common issues that affect individuals as they age. The relaxation of the lower esophageal sphincter, which is responsible for keeping acid in the stomach, is a major cause of heartburn. Additionally, the slowing down of the digestive system with age can also lead to acidity problems. Gastroesophageal reflux disease (GERD), a chronic digestive disorder, is a significant contributor to the market's growth. This condition is characterized by the frequent reflux of stomach acid into the esophagus, leading to heartburn and other symptoms. The rising prevalence of GERD, oesophageal cancer, Barrett's esophagus, milk-alkali syndrome, and rebound hyperacidity are some of the major factors driving the demand for antacid products. Antacids are over-the-counter digestive products that provide dual-action relief from acidity and heartburn. They work by neutralizing stomach acid and reducing the production of acid in the stomach.
Additionally, antacid products come in various forms, including tablets, capsules, liquids, mouth-melting antacids, and injectables. Aluminum hydroxide is a common active ingredient in antacids, but its long-term use can lead to aluminum poisoning, osteomalacia, and hypophosphatemia due to its effect on absorption. Acid-reducing medications, such as proton pump inhibitors and histamine-2 receptor antagonists, are also used to treat acidity and heartburn. However, they have side effects and can lead to dose-dependent rebound hyperacidity. Antacids are an attractive alternative for individuals who experience occasional acidity or heartburn. The antacids market is a significant part of the pharmaceutical sector and includes various players. The market is also influenced by e-commerce and online retail channels, making antacids easily accessible to consumers. Factors such as stress, smoking, alcohol consumption, obesity, and certain medications can trigger acidity and heartburn, leading to an increased demand for antacids. General practitioners and gastroenterologists are the primary prescribers of antacids for symptomatic disorders. The market for antacids is expected to continue its growth trajectory due to the increasing prevalence of gastrointestinal issues and the rising awareness of the importance of managing acidity and heartburn. Thus, such factors are driving the growth of the market during the market forecast period.
The growing e-commerce market is the key trend in the market. The market caters to individuals experiencing heartburn symptoms and other gastrointestinal disorders, including acidity problems and peptic ulcers. Dual-action relief antacids are popular choices for providing quick relief from acid reflux and heartburn. Over-the-counter digestive products, such as antacids, play a significant role in managing various digestive disorders. The geriatric population, in particular, benefits from antacids due to the increased prevalence of acidity issues and conditions like Barrett's esophagus and esophageal cancer. Antacids, including aluminum hydroxide, help neutralize stomach acid, providing instant relief.
However, prolonged use may lead to dose-dependent rebound hyperacidity, aluminum poisoning, osteomalacia, and hypophosphatemia due to absorption issues. Proton pump inhibitors, as prescription medications, offer long-term relief for severe acidity problems. The pharmaceutical sector continues to innovate, introducing injectables and other forms of antacid products. Stress, smoking, alcohol consumption, obesity, and certain medical conditions like milk-alkali syndrome and rebound hyperacidity further contribute to the market growth. General practitioners and gastroenterologists often recommend antacids to manage symptomatic disorders. The antacids market's shift towards e-commerce is noteworthy, with online retail channels offering convenience and accessibility. Consumers can easily purchase antacids without a prescription, making e-commerce an attractive option. Market players are capitalizing on this trend, providing online education and targeted marketing to enhance the shopping experience. The antacids market's growth is further fueled by the increasing prevalence of gastrointestinal issues and the convenience offered by e-commerce channels. Thus, such trends will shape the growth of the market during the forecast period.
The adverse effect of prolonged use of antacids is the major challenge that affects the growth of the market. Antacids are over-the-counter digestive products widely used for providing dual-action relief from heartburn symptoms associated with gastrointestinal disorders, including acidity problems and digestion issues. However, prolonged use or excessive intake of antacids can lead to adverse effects. For instance, antacids containing calcium, such as Maalox, Mylanta, Rolaids, and TUMS, can result in calcium overdose when taken in doses higher than recommended. Calcium overdose may cause nausea, vomiting, mood fluctuations, kidney stones, gas or belching, laxative effect, and swelling of the feet and ankles. Moreover, antacids can lead to the milk-alkali syndrome, which is characterized by metabolic alkalosis and rebound acidity due to dose dependence. Antacids consisting of aluminum hydroxide may cause constipation, aluminum intoxication, osteomalacia, and hypophosphatemia. Antacids containing magnesium have a laxative effect, which can lead to diarrhea. It is essential to follow the recommended dosage to avoid these adverse effects.
Moreover, the geriatric population is at a higher risk of using antacids due to age-related gastrointestinal issues and the prevalence of conditions such as esophageal cancer and Barrett's esophagus. Antacids are also used in the treatment of peptic ulcers and other digestive disorders. However, stress, smoking, alcohol consumption, and obesity can exacerbate acidity, leading to increased antacid consumption. The pharmaceutical sector offers various antacid products, including injectables, to cater to the diverse needs of patients. Antacids are available in various forms, such as tablets, capsules, chewable tablets, and mouth-melting antacids. The antacid market is significant, with e-commerce and online retail channels playing a crucial role in its growth. However, the use of antacids should be monitored closely to prevent dose-dependent rebound hyperacidity and other adverse effects. Hence, the above factors will impede the growth of the market during the forecast period.
The market forecasting report includes the adoption lifecycle of the market, covering from the innovator’s stage to the laggard’s stage. It focuses on adoption rates in different regions based on penetration. Furthermore, the report also includes key purchase criteria and drivers of price sensitivity to help companies evaluate and develop their market growth analysis strategies.
Customer Landscape
Companies are implementing various strategies, such as strategic alliances, partnerships, mergers and acquisitions, geographical expansion, and product/service launches, to enhance their presence in the market.
The market research and growth report also includes detailed analyses of the competitive landscape of the market and information about key companies, including:
Qualitative and quantitative analysis of companies has been conducted to help clients understand the wider business environment as well as the strengths and weaknesses of key market players. Data is qualitatively analyzed to categorize companies as pure play, category-focused, industry-focused, and diversified; it is quantitatively analyzed to categorize companies as dominant, leading, strong, tentative, and weak.
The non-symmetric antacids segment is estimated to witness significant growth during the forecast period. Non-systemic antacids, also referred to as non-absorbable antacids, are a common over-the-counter solution for providing dual-action relief from heartburn symptoms associated with gastrointestinal disorders such as GERD and peptic ulcers.
Get a glance at the market share of various regions Download the PDF Sample
The non-symmetric antacids segment accounted for USD 2.46 billion in 2018. These compounds, which include aluminum hydroxide, calcium carbonate, magnesium carbonate, magnesium hydroxide, and others, are primarily insoluble and do not get absorbed systemically. However, when used in conjunction with proton pump inhibitors or other medications, they can offer significant symptomatic relief. The geriatric population is a significant consumer group for antacid products due to the increased prevalence of acidity problems, including oesophageal cancer and Barrett's esophagus, which can be exacerbated by factors such as stress, smoking, alcohol consumption, and obesity. Milk-alkali syndrome and rebound hyperacidity are other conditions that may require antacid use. Aluminum-containing antacids, such as aluminum hydroxide, are commonly used for their antacid properties.
However, long-term use can lead to aluminum poisoning, resulting in osteomalacia and hypophosphatemia. Calcium- and magnesium-containing antacids are alternative options that do not carry the same risks. Antacid consumption can be dose-dependent, leading to rebound hyperacidity. Therefore, it is essential to consult general practitioners or gastroenterologists for proper dosage and treatment plans. The pharmaceutical sector continues to innovate, offering various antacid products, including injectables, to cater to diverse patient needs. The antacid market is expanding through e-commerce and online retail channels, making these essential digestive products more accessible to consumers. Mouth-melting antacids are a recent addition to the market, providing a more convenient option for those experiencing heartburn symptoms.
For more insights on the market share of various regions Download PDF Sample now!
North America is estimated to contribute 43% to the growth of the global market during the forecast period. Technavio’s analysts have elaborately explained the regional trends and drivers that shape the market during the forecast period. Antacids are over-the-counter (OTC) drugs widely used for the relief of symptoms related to acidity in the stomach, including heartburn and indigestion. These medications come in various forms, such as tablets and liquids, and are available in different compositions, including Sodium Antacids, Calcium Antacids, Magnesium Antacids, and Aluminium Antacids. These alkaline agents neutralize stomach acid, providing relief from pain and inflammation associated with conditions like gastroesophageal reflux disease (GERD) and acid reflux. Antacids are essential in healthcare facilities like hospitals, specialty centers, and hospital pharmacies, as well as in homecare settings and retail pharmacies. They are available in various forms, catering to diverse patient needs.
For instance, Calcium Carbonate antacids are popular for their quick relief of heartburn and acid indigestion, while Aluminum Hydroxide and Magnesium Hydroxide antacids are known for their long-lasting effect. Furthermore, new drugs and medical agents, such as Famotidine, a histamine-2 (H2) blocker, and Calcium Carbonate, an antacid and acid reducer, are increasingly being used to manage gastric diseases, including gastric ulcers and constipation or diarrhea. Antacids are also essential in managing kidney problems, as they help maintain the alkaline balance in the body. In conclusion, antacids play a crucial role in managing various gastrointestinal conditions and are readily available in various healthcare facilities and retail pharmacies.
The market report provides comprehensive data (region-wise segment analysis), with forecasts and estimates in "USD million " for the period 2024-2028, as well as historical data from 2018 - 2022 for the following segments.
Antacids are over-the-counter (OTC) drugs used to provide quick relief from heartburn, indigestion, and other symptoms of acid reflux and gastric diseases. These medications work by neutralizing the stomach acid, reducing the pain and inflammation caused by excess acid in the stomach. The antacids market includes various types such as Sodium Antacids, Calcium Antacids, Precipitate Calcium ,Magnesium Antacids, and Aluminium Antacids. The market for antacids is significant due to the high prevalence of gastric diseases like GERD (Gastroesophageal Reflux Disease) , gastrointestinal over the counter and acid reflux. Antacids are available in different forms, including tablets and liquids, and can be administered orally. They are widely used in hospitals, specialty centers, hospital pharmacies, online pharmacies, retail pharmacies, and even at home for self-medication. Besides relieving heartburn and indigestion, antacids are also used to treat other conditions like gastric ulcers, ingestion, and constipation. New drugs and medical agents like acid reducers, such as famotidine and calcium carbonate, are also gaining popularity in the market. The antacids market is expected to grow due to the increasing healthcare infrastructure and the availability of these medications in various healthcare facilities and retail outlets. However, potential side effects like kidney problems and long-term use can limit the market growth.
Market Scope |
|
Report Coverage |
Details |
Page number |
144 |
Base year |
2023 |
Historic period |
2018 - 2022 |
Forecast period |
2024-2028 |
Growth momentum & CAGR |
Accelerate at a CAGR of 3.27% |
Market growth 2024-2028 |
USD 692.3 million |
Market structure |
Fragmented |
YoY growth 2023-2024(%) |
3.13 |
Regional analysis |
North America, Europe, Asia, and Rest of World (ROW) |
Performing market contribution |
North America at 43% |
Key countries |
US, Germany, Canada, UK, and Brazil |
Competitive landscape |
Leading Companies, Market Positioning of Companies, Competitive Strategies, and Industry Risks |
Key companies profiled |
Advance Pharmaceutical Inc., AmerisourceBergen Corp., Bayer AG, Cardinal Health Inc., GlaxoSmithKline Plc, Humco Holding Group Inc., inovapharma.com, Johnson and Johnson Services Inc., Neogen Corp., Novartis AG, NuCare Laboratories India, Pfizer Inc., Pharmaceutical Associates Inc., Sanofi SA, Sun Pharmaceutical Industries Ltd., The Procter and Gamble Co., United Natural Foods Inc., and WellSpring Pharmaceutical Corp. |
Market dynamics |
Parent market analysis, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID-19 impact and recovery analysis and future consumer dynamics, Market condition analysis for forecast period |
Customization purview |
If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized. |
1 Executive Summary
2 Market Landscape
3 Market Sizing
4 Historic Market Size
5 Five Forces Analysis
6 Market Segmentation by Type
7 Customer Landscape
8 Geographic Landscape
9 Drivers, Challenges, and Opportunity/Restraints
10 Competitive Landscape
11 Competitive Analysis
12 Appendix
Get the report (PDF) sent to your email within minutes.
Get lifetime access to our
Technavio Insights
Quick Report Overview:
Cookie Policy
The Site uses cookies to record users' preferences in relation to the functionality of accessibility. We, our Affiliates, and our Vendors may store and access cookies on a device, and process personal data including unique identifiers sent by a device, to personalise content, tailor, and report on advertising and to analyse our traffic. By clicking “I’m fine with this”, you are allowing the use of these cookies. Please refer to the help guide of your browser for further information on cookies, including how to disable them. Review our Privacy & Cookie Notice.